Sanofi SA
PAR:SAN

Watchlist Manager
Sanofi SA Logo
Sanofi SA
PAR:SAN
Watchlist
Price: 93.17 EUR 2.53% Market Closed
Market Cap: 116.8B EUR
Have any thoughts about
Sanofi SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Sanofi SA

Current Assets 30.1B
Cash & Short-Term Investments 6.8B
Receivables 8.8B
Other Current Assets 14.5B
Non-Current Assets 99.7B
Long-Term Investments 2.6B
PP&E 11.9B
Intangibles 76.7B
Other Non-Current Assets 8.4B
Current Liabilities 30B
Accounts Payable 7.4B
Short-Term Debt 215m
Other Current Liabilities 22.4B
Non-Current Liabilities 27B
Long-Term Debt 14.2B
Other Non-Current Liabilities 12.8B

Balance Sheet
Sanofi SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
7 341
9 148
10 273
10 315
6 925
9 427
13 915
10 098
12 736
8 710
Cash
1 843
1 361
1 077
0
661
701
1 144
1 358
1 385
1 461
Cash Equivalents
5 498
7 787
9 196
10 315
6 264
8 726
12 771
8 740
11 351
7 249
Short-Term Investments
218
111
31
0
199
426
900
1 054
664
270
Total Receivables
9 010
8 853
9 050
7 216
9 345
10 083
9 953
9 787
10 746
11 040
Accounts Receivables
7 149
7 386
7 311
7 216
7 260
7 937
7 491
7 568
8 424
8 433
Other Receivables
1 861
1 467
1 739
0
2 085
2 146
2 462
2 219
2 322
2 607
Inventory
6 562
6 516
6 896
6 818
7 477
7 994
8 352
8 715
8 960
9 666
Other Current Assets
296
300
441
2 005
633
681
583
910
920
969
Total Current Assets
23 427
24 928
26 691
26 354
24 579
28 611
33 703
30 564
34 026
30 655
PP&E Net
10 396
9 943
10 019
9 579
9 651
11 017
10 563
11 976
11 684
11 814
PP&E Gross
10 396
9 943
10 019
0
9 651
11 017
10 563
11 976
11 684
11 814
Accumulated Depreciation
10 484
11 166
11 858
0
13 046
14 134
14 317
15 579
15 112
15 628
Intangible Assets
14 543
12 026
10 879
13 080
21 889
16 509
18 341
21 407
21 640
24 319
Goodwill
39 197
39 557
40 287
40 264
44 235
44 519
44 364
48 056
49 892
49 404
Note Receivable
711
671
776
730
746
521
537
485
452
591
Long-Term Investments
4 189
4 681
4 906
5 428
5 550
5 303
2 129
2 425
2 765
2 666
Other Long-Term Assets
4 929
10 515
11 121
4 378
4 758
6 150
4 776
5 329
6 263
7 015
Other Assets
39 197
39 557
40 287
40 264
44 235
44 519
44 364
48 056
49 892
49 404
Total Assets
97 392
N/A
102 321
+5%
104 679
+2%
99 813
-5%
111 408
+12%
112 630
+1%
114 413
+2%
120 242
+5%
126 722
+5%
126 464
0%
Liabilities
Accounts Payable
3 651
3 817
4 297
4 633
5 041
5 313
5 295
6 180
6 813
7 328
Accrued Liabilities
1 912
1 920
1 967
0
1 989
1 978
2 042
2 126
2 158
2 106
Short-Term Debt
0
228
203
237
249
305
285
189
168
203
Current Portion of Long-Term Debt
858
3 194
1 561
1 038
2 364
4 508
2 714
3 263
4 283
2 117
Other Current Liabilities
6 611
7 666
8 415
9 555
7 733
8 277
8 912
9 537
10 542
12 440
Total Current Liabilities
13 032
16 825
16 443
15 463
17 376
20 381
19 248
21 295
23 964
24 194
Long-Term Debt
13 276
13 023
16 765
14 309
22 071
21 118
20 676
18 962
16 761
16 102
Deferred Income Tax
4 105
2 895
2 292
1 605
3 414
2 294
1 770
1 617
1 841
1 857
Minority Interest
148
161
170
169
159
174
146
350
368
313
Other Liabilities
10 711
11 368
11 457
10 197
9 512
9 607
9 467
9 337
9 004
9 958
Total Liabilities
41 272
N/A
44 272
+7%
47 127
+6%
41 743
-11%
52 532
+26%
53 574
+2%
51 307
-4%
51 561
+0%
51 938
+1%
52 424
+1%
Equity
Common Stock
2 639
2 611
2 584
2 508
2 495
2 508
2 518
2 527
2 522
2 530
Retained Earnings
0
0
0
0
0
0
0
0
0
67 499
Additional Paid In Capital
52 553
52 010
51 475
52 862
53 106
52 049
60 511
63 545
66 859
313
Treasury Stock
694
298
1 503
14
153
9
705
939
706
1 184
Other Equity
1 622
3 726
4 996
2 714
3 428
4 508
782
3 548
6 109
4 882
Total Equity
56 120
N/A
58 049
+3%
57 552
-1%
58 070
+1%
58 876
+1%
59 056
+0%
63 106
+7%
68 681
+9%
74 784
+9%
74 040
-1%
Total Liabilities & Equity
97 392
N/A
102 321
+5%
104 679
+2%
99 813
-5%
111 408
+12%
112 630
+1%
114 413
+2%
120 242
+5%
126 722
+5%
126 464
0%
Shares Outstanding
Common Shares Outstanding
1 310
1 302
1 272
1 254
1 245
1 254
1 251
1 253
1 253
1 251

See Also

Discover More